FDA

Since pharmaceutical companies started funding their FDA drug applications 30 years ago, the agency’s reviews have gone much faster — perhaps too fast.

A controversial new drug for ALS could add months to patients' lives – if it actually works

A cannabis product called delta-8 was made legal when the 2018 Farm Bill legalized hemp. But unlike its cousin CBD, delta-8 has psychoactive properties. And the FDA warns it has “serious health risks.” The agency has received more than 100 reports of bad reactions among people who consumed it.

U.S. health regulators say their response to the ongoing infant formula shortage was slowed by delays in processing a whistleblower complaint and test samples from the nation’s largest formula factory.

In March, experts who advise the FDA questioned the efficacy of an experimental new drug for ALS. In September, they voted to approve it anyway.

Frank Jones didn't see the truck that just missed him. Didn't hear it either. Though he has gone to an audiologist, he says cost has held him back from getting hearing aids. A new FDA policy could change that.

The ruling is a remarkable turnaround for the much-debated medication that was previously rejected by the same group this year.

The new shots from Moderna and Pfizer-BioNTech target both the original strain of the coronavirus and the omicron BA.4/BA.5 subvariants that most people are catching now.

The lawsuit, filed in federal court in Tampa, came after AHCA Secretary Simone Marstiller submitted a Freedom of Information Act request seeking numerous records about importation proposals by Florida and other states.

The Food and Drug Administration is planning to authorize a new generation of COVID-19 boosters this week that for the first time will target the omicron variant.